Lipid Changes During Endocrine Therapy in Breast Cancer Patients: The Results of a 5-Year Real-World Retrospective Analysis.
Abstract | BACKGROUND: The aim of this study was to investigate the status of serum lipids during endocrine therapy. METHODS: RESULTS: For premenopausal BC patients, LDL levels rapidly decreased at 1 year in the tamoxifen (TAM) group compared with baseline levels (p<0.05), and this decline remained for the following 4 years. Additionally, LDL levels were significantly lower in the TAM group than in the nonendocrine group at all assessment time points (p<0.05). Similarly, TC levels also decreased in the TAM group compared with baseline levels at all assessment time points (p<0.05), and compared with the levels in the nonendocrine group, TC levels were also lower for the first 4 years. For postmenopausal BC patients, there was no significant difference in the lipid profiles (TG, TC, LDL and HDL) in the letrozole (LET), anastrozole (ANA) or exemestane (EXE) groups compared with the nonendocrine group. For patients who received TAM, compared with the nonendocrine group, TC levels decreased at 1 year, and LDL levels decreased at 1 and 2 years. CONCLUSIONS: TAM may improve LDL and TC levels in premenopausal BC patients. In postmenopausal BC patients, aromatase inhibitors (AIs) may have no adverse effects on lipid profiles, and TAM may have limited beneficial effects on serum lipids.
|
Authors | Tao He, Xu Li, Jiayuan Li, Zhu Wang, Yuan Fan, Xiusong Li, Zhoukai Fu, Yunhao Wu, Qing Lv, Ting Luo, Xiaorong Zhong, Jie Chen |
Journal | Frontiers in oncology
(Front Oncol)
Vol. 11
Pg. 670897
( 2021)
ISSN: 2234-943X [Print] Switzerland |
PMID | 35111662
(Publication Type: Journal Article)
|
Copyright | Copyright © 2022 He, Li, Li, Wang, Fan, Li, Fu, Wu, Lv, Luo, Zhong and Chen. |
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|